- Home
- BFRI
BFRI
Biofrontera Inc.
as 11-14-2025 4:00pm EST
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
| Founded: | 1997 | Country: | United States |
| Employees: | N/A | City: | WOBURN |
| Market Cap: | 11.1M | IPO Year: | 2021 |
| Target Price: | $2.75 | AVG Volume (30 days): | 201.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.92 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.54 - $1.87 | Next Earning Date: | 11-12-2025 |
| Revenue: | $37,164,000 | Revenue Growth: | 5.11% |
| Revenue Growth (this year): | 9.7% | Revenue Growth (next year): | 12.58% |
Latest Biofrontera Inc. News
BFRI Breaking Stock News: Dive into BFRI Ticker-Specific Updates for Smart Investing
GlobeNewswire
10 days ago
Biofrontera Inc. announces sale of license to Xepi® Antibiotic Cream to Pelthos Therapeutics Inc. for up to $10M
GlobeNewswire
10 days ago
Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing
Zacks
11 days ago
Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates
GlobeNewswire
11 days ago
Biofrontera Inc. to Report Third Quarter 2025 Financial Results on November 12, 2025 and Host a Conference Call on November 13, 2025
Zacks
12 days ago
Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Tops Revenue Estimates
Zacks
13 days ago
PTC Therapeutics (PTCT) Q3 Earnings and Revenues Top Estimates
Yahoo Finance Video
22 days ago
AI will 'amplify, not replace' human performance: Workday CEO
Yahoo Finance
22 days ago
'Premature to signal the all-clear': Markets cheered the CPI print — but Main Street isn’t feeling the relief
Compare BFRI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BFRI Biofrontera Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.